{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:36:21Z","timestamp":1785443781206,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jviromet.2023.114733","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T18:41:29Z","timestamp":1681584089000},"page":"114733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["\u03b2-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training"],"prefix":"10.1016","volume":"317","author":[{"given":"Veronika","family":"Pilchov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittappen Kandiyil","family":"Prajeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Jendrny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Twele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Pink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn Martina","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger Andreas","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"von K\u00f6ckritz-Blickwede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2023.114733_bib1","unstructured":"ABAS 2021. Ausschuss f\u00fcr Biologische Arbeitsstoffe, 1\u20135. https:\/\/doi.org\/https:\/\/www.baua.de\/DE\/Aufgaben\/Geschaeftsfuehrung-von-Ausschuessen\/ABAS\/pdf\/SARS-CoV-2_6\u20132020.pdf?__blob=publicationFile."},{"key":"10.1016\/j.jviromet.2023.114733_bib2","article-title":"Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: a preclinical study","author":"Abdoli","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jviromet.2023.114733_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-8177(86)23012-3","article-title":"Oral food clearance and the pH of plaque and saliva","volume":"112","author":"Bibby","year":"1986","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.jviromet.2023.114733_bib4","unstructured":"Binder, M., 2017. TCID50 calculator (v2.1 - 20\u201301-2017_MB) (WWW Document). https:\/\/www.klinikum.uni-heidelberg.de\/zentrum-fuer-infektiologie\/molecular-virology\/welcome\/downloads."},{"key":"10.1016\/j.jviromet.2023.114733_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-1110(77)90007-0","article-title":"The genetic properties of beta-propiolactone","volume":"39","author":"Brusick","year":"1977","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jviromet.2023.114733_bib6","first-page":"35","article-title":"Large scale production and characterization of SARS\u2010CoV\u20102 whole antigen for serological test development","author":"Cerutti","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jviromet.2023.114733_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omtm.2021.08.005","article-title":"Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jviromet.2023.114733_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2022.05.012","article-title":"Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model","volume":"147","author":"de Castro Barbosa","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jviromet.2023.114733_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/d41586-020-03149-9","article-title":"Can dogs smell COVID? Here\u2019s what the science says","volume":"587","author":"Else","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jviromet.2023.114733_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/pathogens11020271","article-title":"Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes","volume":"11","author":"Elveborg","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jviromet.2023.114733_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250158","article-title":"Discrimination of SARS-CoV-2 infected patient samples by detection dogs: a proof of concept study","volume":"16","author":"Essler","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2023.114733_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2023.114733_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262631","article-title":"Identifying SARS-COV-2 infected patients through canine olfactive detection on axillary sweat samples; study of observed sensitivities and specificities within a group of trained dogs","volume":"17","author":"Grandjean","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2023.114733_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198555","article-title":"Inactivation of SARS-CoV-2 by \u03b2-propiolactone causes aggregation of viral particles and loss of antigenic potential","volume":"305","author":"Gupta","year":"2021","journal-title":"Virus Res."},{"key":"10.1016\/j.jviromet.2023.114733_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02232-9","article-title":"The detection dogs test is more sensitive than real-time PCR in screening for SARS-CoV-2","volume":"4","author":"Hag-Ali","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jviromet.2023.114733_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/am.9.4.278-282.1961","article-title":"Comparative effects of \u03b2-propiolactone on mice, mouse-derived cell cultures, and venezuelan equine encephalomyelitis virus","volume":"9","author":"Hearn","year":"1961","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114733_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/tbed.13885","article-title":"Animals and SARS\u2010CoV\u20102: species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission","volume":"68","author":"Hobbs","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.jviromet.2023.114733_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12879-020-05281-3","article-title":"Scent dog identification of samples from COVID-19 patients - a pilot study","volume":"20","author":"Jendrny","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114733_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06523-8","article-title":"Canine olfactory detection and its relevance to medical detection","author":"Jendrny","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114733_bib20","first-page":"21","article-title":"Scent dog identification of SARS-CoV-2 infections in different body fluids","author":"Jendrny","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114733_bib21","first-page":"15","article-title":"Sporicidal activity of peracetic acid and \u03b2-propiolactone at subzero temperatures","author":"Jones","year":"1967","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114733_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/v12060622","article-title":"Propagation, inactivation, and safety testing of SARS-CoV-2","volume":"12","author":"Jureka","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2023.114733_bib23","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1002\/jev2.12291","article-title":"Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS\u2010CoV\u20102 infected human lung epithelial cells","volume":"11","author":"Kongsomros","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jviromet.2023.114733_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2021.1971569","article-title":"Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies","author":"Kozlovskaya","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2023.114733_bib25","doi-asserted-by":"crossref","unstructured":"Kusters, I.C., Matthews, J., Saluzzo, J.F., 2009. In: Barrett, A.D.T., Stanberry, L.R.B.T.-V. for B. and E., N.D. (Eds.), Chapter 11 - Manufacturing Vaccines for an Emerging Viral Infection\u2013Specific Issues Associated with the Development of a Prototype SARS Vaccine, Academic Press, London, 147\u2013156. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/B978\u20130-12\u2013369408-9.00011\u20131.","DOI":"10.1016\/B978-0-12-369408-9.00011-1"},{"key":"10.1016\/j.jviromet.2023.114733_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpha.2018.06.003","article-title":"Gas chromatography-mass spectrometry method for determination of \u03b2-propiolactone in human inactivated rabies vaccine and its hydrolysis analysis","volume":"8","author":"Lei","year":"2018","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jviromet.2023.114733_bib27","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1021\/ja990592p","article-title":"Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2\u03b3-hydroxyl group","volume":"121","author":"Li","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jviromet.2023.114733_bib28","first-page":"6","article-title":"Pathophysiology of SARS-CoV-2 infection in the upper respiratory tract and its relation to breath volatile organic compounds","author":"Lichtenstein","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.jviromet.2023.114733_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jama.1957.02980030034008","article-title":"Beta-propiolactone in sterilization of vaccines, tissue grafts, and plasma","volume":"164","author":"LoGrippo","year":"1957","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jviromet.2023.114733_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.1960.tb40931.x","article-title":"Investigations of the use of beta-propiolactone in virus inactivation","author":"LoGrippo","year":"1960","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jviromet.2023.114733_bib31","series-title":"Virologische Arbeitsmethoden. Band I","first-page":"35","article-title":"Quantitative Bestimmung der Virusinfektiosit\u00e4t (Virustitration)","author":"Mayr","year":"1974"},{"key":"10.1016\/j.jviromet.2023.114733_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1015620","article-title":"Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections","volume":"9","author":"Meller","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jviromet.2023.114733_bib33","first-page":"3","article-title":"Preliminary accuracy of COVID-19 odor detection by canines and HS-SPME-GC-MS using exhaled breath samples","author":"Mendel","year":"2021","journal-title":"Forensic Sci. Int. Synerg."},{"key":"10.1016\/j.jviromet.2023.114733_bib34","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/jsfa.1577","article-title":"Kinetics of ultraviolet light inactivation ofEscherichia coli O157:H7 in liquid foods","volume":"83","author":"Ngadi","year":"2003","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.jviromet.2023.114733_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/biol.1995.0034","article-title":"Inactivation of DNA by beta-propiolactone","volume":"23","author":"Perrin","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2023.114733_bib36","article-title":"Early immune response in mice immunized with a semi-split inactivated vaccine against SARS-CoV-2 containing S protein-free particles and subunit S protein","author":"Petr\u00e1\u0161","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jviromet.2023.114733_bib37","unstructured":"Pilchov\u00e1, V., Mergani, A.E., Clever, S., Ciurkiewicz, M., Becker, K., Gerhauser, I., Baumg\u00e4rtner, W., Volz, A., von K\u00f6ckritz-Blickwede, M., Schulz, C., n.d. . SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories. In revision at. Vet. Pathol."},{"key":"10.1016\/j.jviromet.2023.114733_bib38","first-page":"1","article-title":"Culture of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; f.2019-nCoV)","volume":"2","author":"Pyke","year":"2020","journal-title":"Protocols.Io"},{"key":"10.1016\/j.jviromet.2023.114733_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/vim.2010.0028","article-title":"Immunogenicity and protective efficacy in mice and hamsters of a \u03b2-propiolactone inactivated whole virus SARS-CoV vaccine","volume":"23","author":"Roberts","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jviromet.2023.114733_bib40","first-page":"135","article-title":"Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt","volume":"4","author":"Saleh","year":"2021","journal-title":"Antib. Ther."},{"key":"10.1016\/j.jviromet.2023.114733_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jviromet.2016.04.013","article-title":"Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus","volume":"235","author":"Sasaki","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2023.114733_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/CMR.00020-13","article-title":"Clinical application of volatile organic compound analysis for detecting infectious diseases","volume":"26","author":"Sethi","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jviromet.2023.114733_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/acs.chemrestox.9b00389","article-title":"Carcinogenesis of \u03b2-propiolactone: a computational study","volume":"33","author":"\u0160paninger","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jviromet.2023.114733_bib44","first-page":"118","article-title":"Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein","author":"Tai","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jviromet.2023.114733_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/104454904323145272","article-title":"Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB\/c mice","volume":"23","author":"Tang","year":"2004","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jviromet.2023.114733_bib46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj1060829","article-title":"Reaction of beta-propiolactone with amino acids and its specificity for methionine","volume":"106","author":"Taubman","year":"1968","journal-title":"Biochem. J."},{"key":"10.1016\/j.jviromet.2023.114733_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.749588","article-title":"Discrimination of SARS-CoV-2 infections from other viral respiratory infections by scent detection dogs","volume":"8","author":"ten Hagen","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jviromet.2023.114733_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-010276","article-title":"Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event","volume":"7","author":"ten Hagen","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jviromet.2023.114733_bib49","doi-asserted-by":"crossref","first-page":"36198","DOI":"10.1074\/jbc.M111.279232","article-title":"Reactions of \u03b2-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses","volume":"286","author":"Uittenbogaard","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2023.114733_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2023.114733_bib51","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3390\/molecules27123917","article-title":"Rational design of peptides derived from odorant-binding proteins for SARS-CoV-2-related volatile organic compounds recognition","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jviromet.2023.114733_bib52","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1128\/jvi.64.6.3051-3055.1990","article-title":"Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions","volume":"64","author":"Weismiller","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2023.114733_bib53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/infdis\/jiaa405","article-title":"Susceptibility of tick-borne encephalitis virus to inactivation by heat, acidic pH, chemical, or UV treatment","volume":"223","author":"Wiesner","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114733_bib54","article-title":"Virological assessment of hospitalized cases of coronavirus disease 2019","author":"W\u00f6lfel","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jviromet.2023.114733_bib55","unstructured":"WOAH 2020. Infection with SARS-CoV-2 in Animals. https:\/\/www.woah.org\/fileadmin\/Home\/eng\/Our_scientific_expertise\/docs\/pdf\/COV-19\/A_Factsheet_SARS-CoV-2.pdf."},{"key":"10.1016\/j.jviromet.2023.114733_bib56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials","volume":"324","author":"Xia","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jviromet.2023.114733_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetmic.2018.10.003","article-title":"Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage","volume":"226","author":"Zhugunissov","year":"2018","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114733_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179020","article-title":"SARS-CoV-2 short-time infection produces relevant cytopathic effects in vero E6 cell line","author":"Zupin","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:41Z","timestamp":1759056941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093423000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":58,"alternative-id":["S0166093423000587"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114733","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114733"}}